U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07661121) titled 'EMVITAL + EMFACE Combination Therapy for Temporomandibular Joint (TMJ) Pain Relief' on June... Read More
U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07660484) titled 'Link Between ASCorbemia Level and Osteoporosis' on June 16. Brief Summary: This monocentri... Read More
U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07659379) titled 'Gotistobart Long Term Extension (LTE) Study' on June 15. Brief Summary: This LTE study wil... Read More
U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07658352) titled 'A First-in-Human Study of HP-002 for Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma' on... Read More
Singapore, June 23 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating ... Read More
Singapore, June 23 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pla... Read More
U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07660029) titled 'BloodTrackR Usability and Concordance Study (BUCS): Evaluating a Smart Home-Based Blood Col... Read More
Singapore, June 23 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solut... Read More
Singapore, June 23 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib M... Read More
Singapore, June 23 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembr... Read More